GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » H. Lundbeck AS (LTS:0ABR) » Definitions » Pre-Tax Income

H. Lundbeck AS (LTS:0ABR) Pre-Tax Income : kr3,214 Mil (TTM As of Sep. 2024)


View and export this data going back to 2022. Start your Free Trial

What is H. Lundbeck AS Pre-Tax Income?

Pretax income is the income that a company earns before paying income taxes. H. Lundbeck AS's pretax income for the three months ended in Sep. 2024 was kr732 Mil. Its pretax income for the trailing twelve months (TTM) ended in Sep. 2024 was kr3,214 Mil. H. Lundbeck AS's pretax margin was 12.79%.

During the past 13 years, H. Lundbeck AS's highest Pretax Margin was 29.59%. The lowest was -48.01%. And the median was 13.68%.


H. Lundbeck AS Pre-Tax Income Historical Data

The historical data trend for H. Lundbeck AS's Pre-Tax Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

H. Lundbeck AS Pre-Tax Income Chart

H. Lundbeck AS Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Pre-Tax Income
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3,026.00 1,906.00 1,581.00 2,474.00 2,993.00

H. Lundbeck AS Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Pre-Tax Income Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 883.00 175.00 1,307.00 1,000.00 732.00

Competitive Comparison of H. Lundbeck AS's Pre-Tax Income

For the Drug Manufacturers - Specialty & Generic subindustry, H. Lundbeck AS's Pre-Tax Income, along with its competitors' market caps and Pre-Tax Income data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


H. Lundbeck AS's Pre-Tax Income Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, H. Lundbeck AS's Pre-Tax Income distribution charts can be found below:

* The bar in red indicates where H. Lundbeck AS's Pre-Tax Income falls into.



H. Lundbeck AS Pre-Tax Income Calculation

This is the income that a company earns before paying income taxes.

H. Lundbeck AS's Pretax Income for the fiscal year that ended in Dec. 2023 is calculated as

Pretax Income=Operating Income+Non Operating Income+Interest Expense+Interest Income+Other
=3195+0+-54+86+-234
=2,993

H. Lundbeck AS's Pretax Income for the quarter that ended in Sep. 2024 is calculated as

Pretax Income=Operating Income+Non Operating Income+Interest Expense+Interest Income+Other
=811+0+-79+0+0
=732

Pre-Tax Income for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was kr3,214 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


H. Lundbeck AS  (LTS:0ABR) Pre-Tax Income Explanation

H. Lundbeck AS's Pretax Margin for the quarter that ended in Sep. 2024 is calculated as

Pretax Margin=Pretax Income/Revenue
=732/5722
=12.79%

During the past 13 years, H. Lundbeck AS's highest Pretax Margin was 29.59%. The lowest was -48.01%. And the median was 13.68%.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


H. Lundbeck AS Pre-Tax Income Related Terms

Thank you for viewing the detailed overview of H. Lundbeck AS's Pre-Tax Income provided by GuruFocus.com. Please click on the following links to see related term pages.


H. Lundbeck AS Business Description

Address
Ottiliavej 9, Valby, DNK, 2500
Lundbeck is a Denmark-based pharmaceutical firm that focuses on the development and commercialization of central nervous system drugs including antidepressants, antipsychotics, and antiepileptic products. The company's portfolio includes Abilify Maintena and Rexulti for psychosis, Brintellix/Trintellix for depression, Northera for Parkinson's disease symptoms, Sabril and Onfi for seizures, and Vyepti for migraine prevention. Most of the company's sales are derived in North America, followed by Asia and Europe.

H. Lundbeck AS Headlines

No Headlines